QDENGA subst sèche c solv flac
7680694030014
Pharmacode 1120213
CH-69403
J07BX04
08.08.
1 / 3
google
Details
- GTIN
- 7680694030014
- Pharmacode
- 1120213
- Product number
- 6940301
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Vaccinum attenuatum: virus Dengue typus 1 vivus attenuatum ≥3.3 log10PFU/dose pro dosi, virus Dengue typus 2 vivus attenuatum ≥2.7 log10PFU/dose pro dosi, virus Dengue typus 3 vivus attenuatum ≥4.0 log10PFU/dose pro dosi, virus Dengue typus 4 vivus attenuatum ≥4.5 log10PFU/dose pro dosi, trehalosum dihydricum, poloxamerum 407, albuminum seri humani, kalii dihydrogenophosphas, natrii dihydrogenophosphas dihydricus, kalii chloridum, natrii chloridum, pro vitro. Solvens: aqua ad iniectabile 0.5 ml, pro vitro.
Articles (1)
Qdenga 0.5 ml, Pulver und Lösungsmittel für eine Injektionslösung in einer vorgefüllten Spritze
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
virus Dengue typus 1 vivus attenuatum
|
- | Substance | Wirkstoff (Principe actif) |
|
aqua ad iniectabile
|
0.5 ML | Substance | HNIDK |
|
virus Dengue typus 2 vivus attenuatum
|
- | Substance | Wirkstoff (Principe actif) |
|
virus Dengue typus 3 vivus attenuatum
|
- | Substance | Wirkstoff (Principe actif) |
|
virus Dengue typus 4 vivus attenuatum
|
- | Substance | Wirkstoff (Principe actif) |
|
trehalosum dihydricum
|
- | Substance | HNIDK |
|
poloxamerum 407
|
- | Substance | HNIDK |
|
albuminum seri humani
|
- | Substance | HNIDK |
|
kalii dihydrogenophosphas
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas dihydricus
|
- | Substance | HNIDK |
|
kalii chloridum
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 69403
- Drug name
- Qdenga, Pulver und Lösungsmittel für eine Injektionslösung
- Galenic form
- PULIL
- ATC Code
- J07BX04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/07/2024
- Authorization expiration date
- 28/07/2029
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- QDENGA subst sèche c solv flac
- Description (DE)
- QDENGA Trockensub c Solv Durchstf
- Market launch
- 29/07/2024
- Narcotic (BTM)
- No
Application methods
SUBC